Table of Contents Author Guidelines Submit a Manuscript
Journal of Skin Cancer
Volume 2011, Article ID 874571, 11 pages
http://dx.doi.org/10.1155/2011/874571
Clinical Study

Inhibition of Epidermal Growth Factor Receptor and PI3K/Akt Signaling Suppresses Cell Proliferation and Survival through Regulation of Stat3 Activation in Human Cutaneous Squamous Cell Carcinoma

1Division of Dermatology, Department of Clinical Molecular Medicine, Faculty of Medicine, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
2Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan

Received 6 August 2010; Accepted 11 October 2010

Academic Editor: M. Lebwohl

Copyright © 2011 Toshinori Bito et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Sumita, T. Bito, K. Nakajima, and C. Nishigori, “Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines,” Experimental Dermatology, vol. 15, no. 4, pp. 291–299, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. K. G. Neiva, Z. Zhang, M. Miyazawa, K. A. Warner, E. Karl, and J. E. Nör, “Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling,” Neoplasia, vol. 11, no. 6, pp. 583–593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Vasiljević, K. Andersson, K. Bjelkenkrantz et al., “The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma,” International Journal of Cancer, vol. 124, no. 10, pp. 2361–2366, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Prenzel, O. M. Fischer, S. Streit, S. Hart, and A. Ullrich, “The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification,” Endocrine-Related Cancer, vol. 8, no. 1, pp. 11–31, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Carpenter and S. Cohen, “epidermal growth factor,” Annual Review of Biochemistry, vol. 48, pp. 193–216, 1979. View at Google Scholar · View at Scopus
  6. F. Cappuzzo, V. Gregorc, E. Rossi et al., “Gefitinib in pretreated non-small-cell lung cancer (NSCLC): analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced or metastatic NSCLC,” Journal of Clinical Oncology, vol. 21, no. 14, pp. 2658–2663, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. I.-H. Chen, J. T. Chang, C.-T. Liao, H.-M. Wang, L.-L. Hsieh, and A.-J. Cheng, “Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area,” British Journal of Cancer, vol. 89, no. 4, pp. 681–686, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. D. K. Gaffney, D. Haslam, A. Tsodikov et al., “Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 56, no. 4, pp. 922–928, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Ma, H. Lin, S. S. Leonard, X. Shi, J. Ye, and J. Luo, “Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro,” Oncogene, vol. 22, no. 34, pp. 5281–5290, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Berclaz, H. J. Altermatt, V. Rohrbach, A. Siragusa, E. Dreher, and P. D. Smith, “EGFR dependent expression of STAT3 (but not STAT1) in breast cancer,” International Journal of Oncology, vol. 19, no. 6, pp. 1155–1160, 2001. View at Google Scholar · View at Scopus
  11. H. Shao, H. Y. Cheng, R. G. Cook, and D. J. Tweardy, “Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor,” Cancer Research, vol. 63, no. 14, pp. 3923–3930, 2003. View at Google Scholar · View at Scopus
  12. D. K. Tsang and D. L. Crowe, “The mitogen activated protein kinase pathway is required for proliferation but not invasion of human squamous cell carcinoma lines,” International Journal of Oncology, vol. 15, no. 3, pp. 519–523, 1999. View at Google Scholar · View at Scopus
  13. J. Snaddon, E. K. Parkinson, J. A. Craft, C. Bartholomew, and R. Fulton, “Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus,” British Journal of Cancer, vol. 84, no. 12, pp. 1630–1634, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. M. J. Worsham, G. Pals, J. P. Schouten et al., “Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma,” Archives of Otolaryngology—Head and Neck Surgery, vol. 129, no. 7, pp. 702–708, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Vanhaesebroeck and M. D. Waterfield, “Signaling by distinct classes of phosphoinositide 3-kinases,” Experimental Cell Research, vol. 253, no. 1, pp. 239–254, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. C. C. Bancroft, Z. Chen, J. Yeh et al., “Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-κB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines,” International Journal of Cancer, vol. 99, no. 4, pp. 538–548, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Kondo and K. Aso, “Establishment of a cell line of human skin squamous cell carcinoma in vitro,” British Journal of Dermatology, vol. 105, no. 2, pp. 125–132, 1981. View at Google Scholar · View at Scopus
  18. P. Boukamp, R. T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, and N. E. Fusenig, “Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line,” Journal of Cell Biology, vol. 106, no. 3, pp. 761–771, 1988. View at Google Scholar · View at Scopus
  19. E. Corsini, A. Terzoli, A. Bruccoleri, M. Marinovich, and C. L. Galli, “Induction of tumor necrosis factor-α in vivo by a skin irritant, tributyltin, through activation of transcription factors: its pharmacological modulation by anti-inflammatory drugs,” Journal of Investigative Dermatology, vol. 108, no. 6, pp. 892–896, 1997. View at Google Scholar · View at Scopus
  20. S. Roy, C. K. Sen, H. Kobuchi, and L. Packer, “Antioxidant regulation of phorbol ester-induced adhesion of human Jurkat T-cells to endothelial cells,” Free Radical Biology and Medicine, vol. 25, no. 2, pp. 229–241, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Vermes, C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger, “A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V,” Journal of Immunological Methods, vol. 184, no. 1, pp. 39–51, 1995. View at Publisher · View at Google Scholar · View at Scopus
  22. K. S. Chan, S. Carbajal, K. Kiguchi, J. Clifford, S. Sano, and J. DiGiovanni, “Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis,” Cancer Research, vol. 64, no. 7, pp. 2382–2389, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Sriuranpong, J. I. Park, P. Amornphimoltham, V. Patel, B. D. Nelkin, and J. S. Gutkind, “Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system,” Cancer Research, vol. 63, no. 11, pp. 2948–2956, 2003. View at Google Scholar · View at Scopus
  24. Y. Umekita, Y. Ohi, Y. Sagara, and H. Yoshida, “Co-expression of epidermal growth factor receptor and transforming growth factor-α predicts worse prognosis in breast-cancer patients,” International Journal of Cancer, vol. 89, no. 6, pp. 484–487, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Pennock and Z. Wang, “Stimulation of cell proliferation by endosomal epidermal growth factor receptor as revealed through two distinct phases of signaling,” Molecular and Cellular Biology, vol. 23, no. 16, pp. 5803–5815, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. C. B. Knobbe and G. Reifenberger, “Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3'-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas,” Brain Pathology, vol. 13, no. 4, pp. 507–518, 2003. View at Google Scholar · View at Scopus
  27. M. R. D. Quadros, F. Peruzzi, C. Kari, and U. Rodeck, “Complex regulation of signal transducers and activators of transcription 3 activation in normal and malignant keratinocytes,” Cancer Research, vol. 64, no. 11, pp. 3934–3939, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Samuels, Z. Wang, A. Bardelli et al., “High frequency of mutations of the PIK3CA gene in human cancers,” Science, vol. 304, no. 5670, p. 554, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. W.-L. Shih, M.-H. Liao, P.-Y. Lin et al., “PI 3-kinase/Akt and STAT3 are required for the prevention of TGF-β-induced Hep3B cell apoptosis by autocrine motility factor/phosphoglucose isomerase,” Cancer Letters, vol. 290, pp. 223–237, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. A. R. Conery, Y. Cao, E. A. Thompson, C. M. Townsend Jr., T. C. Ko, and K. Luo, “Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β-induced apoptosis,” Nature Cell Biology, vol. 6, no. 4, pp. 366–372, 2004. View at Publisher · View at Google Scholar · View at Scopus